These are standard Form 3 filings for new insiders post-IPO or appointment. No trading signal. Monitor future Form 4 filings for any insider purchases or sales that may indicate conviction levels.
Price Chart
Executive Summary
Two initial statements of beneficial ownership (Form 3) were filed for Seaport Therapeutics (SPTX) by incoming officer Antony Loebel (Chief Medical Officer) and director Robert Hombach. Loebel reports direct ownership of 20,109 common shares and options to acquire 608,279 shares at exercise prices ranging from $3.05 to $10.31. Hombach reports options to acquire 89,300 shares at $7.39 and $10.31. These filings are routine insider onboarding disclosures with no material financial impact.
Key Facts
- Antony Loebel appointed Chief Medical Officer, filed Form 3 disclosing 20,109 common shares and options for 608,279 shares
- Robert Hombach appointed director, filed Form 3 disclosing options for 89,300 shares
- Loebel's options have exercise prices of $3.05, $7.39, and $10.31 with varying vesting schedules
- Hombach's options have exercise prices of $7.39 and $10.31 with vesting over 24-36 months
- Both filings include standard Power of Attorney designations for Section 16 compliance
Financial Impact
No financial impact — routine insider onboarding disclosures
Risk Factors
- No material risks identified from these filings
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (SPTX) — Batch item 1 | 0001193125-26-198489 |
| Document: 0001193125-26-198489-index-headers.html | 0001193125-26-198491 |
| Document: 0001193125-26-198489-index.html | 0001193125-26-198489 |
| Document: 0001193125-26-198489.txt | 0001193125-26-198489 |
| 3 Filing (SPTX) — Batch item 5 | 0001193125-26-198491 |
| Document: 0001193125-26-198491-index-headers.html | 0001193125-26-198489 |
| Document: 0001193125-26-198491-index.html | 0001193125-26-198489 |
| Document: 0001193125-26-198491.txt | 0001193125-26-198489 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $20.65 | awaiting T+60 | — | $20.83 (+0.87%) |
Jun 8, 2026 20w ago | 8-K | $16.20 $23.61 | ▲ +45.74% | ▲ +42.69% | $20.83 (+28.58%) |
May 6, 2026 24w ago | 3 | $15.50 $20.65 | ▲ +33.23% | ▲ +29.39% | $20.83 (+34.39%) |
May 1, 2026 25w ago | 424B4 | $17.00 $19.74 | ▲ +16.12% | ▲ +14.26% | $20.83 (+22.53%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $20.83 (+4.99%) |
Apr 27, 2026 26w ago | S-1/A | — | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers